Melky Cabrera signed a two-year, $16 million contract with the Blue Jays, which seems pretty good given that he hasn’t played since getting slapped with a 50-game PED suspension and then got kicked to the curb by the Giants when he was eligible to return in the postseason.
Still, it’s a two-year deal at a fraction of what he figured to get previously. Even if he slumped some during the final month and a half and into the postseason, he was likely looking at something in the neighborhood of $50 million for four years as a free agent this winter. A strong finish could have netted him $70 million for five years.
So why lock into that extra year? Cabrera was no second-year guy needing financial security in the form of a long-term deal; he’s already earned about $11 million in his career. He could afford to gamble if he were confident in his ability to bounce back and put together a strong 2013 season. We may never know whether the Jays would have signed him to a one-year, $8 million deal if that’s what he preferred — they may have wanted that extra upside the second year provides — but it’s hard to imagine they or someone else wouldn’t have given him at least $6 million for 2013 alone.
It suggests to me that Cabrera doesn’t see himself coming back and having another season like his 2012. Because if he did, he would have taken the one-year deal and then chased the big payday.
Maybe I’m wrong. And I don’t want this to read as a condemnation of Cabrera. But it’s intriguing to me. I think of most athletes as supremely confident in their abilities on the field (or the court, track, rink, etc.). And while Melky took his game to a whole new level in 2012, he was also something much more than an $8 million player with the Royals in 2011. If he isn’t confident he can get back to that — if he doesn’t think of himself as being worth $15 million per year or what have you — then I’m not all that sure I’d want to sign him at any price.
It’s been a miserable weekend for Nationals’ outfielder Adam Eaton, who stumbled over first base and injured his leg while running out an infield single in Friday’s 4-3 win over the Mets. While the team officially placed the outfielder on the 10-day disabled list with a left knee strain on Saturday, FOX Sports’ Ken Rosenthal reports that Eaton has been diagnosed with a torn ACL in his left knee and is expected to miss the remainder of the 2017 season. The team has yet to confirm the diagnosis or announce a definite timetable for the 28-year-old’s return, perhaps due to extended evaluations by Eaton’s orthopedic doctor:
The Nationals appear to have several outfield options with Eaton on the disabled list, though they have not pinned down a long-term solution. Center fielder Michael Taylor replaced Eaton on the field during the tail end of Friday’s game, and returned on Saturday to man center and bat second in the lineup. The club also promoted top outfield prospect Rafael Bautista, who slashed .291/.325/.354 with five doubles and a .680 OPS through 19 games in Triple-A Syracuse this season. He’ll assume Eaton’s roster spot and looks to be available for a backup role in the outfield going forward.
Last we heard from Shelby Miller, the Diamondbacks’ right-hander was contemplating Tommy John surgery for a partial UCL tear in his right elbow. Now, he appears to have decided to go through with the procedure.
Miller decided to skip Tommy John alternatives like plasma-rich platelet injections or stem cell treatment, which have been used to varying degrees of success by other major league pitchers with similar injuries. The surgery will set him back an estimated 12-18 months, FanRag Sports’ Tommy Stokke reports, which puts Miller’s estimated return date somewhere in 2018 if all goes well.
The 26-year-old starter was off to a rocky start this season, posting a 2-2 record and 4.09 ERA through 22 innings and striking out just 20 of 99 batters faced. This was his sophomore campaign in Arizona after muddling through the 2016 season with a 3-12 record, 6.15 ERA and 0.5 fWAR over 101 innings with the club.